Zhitong Finance App News, Federal Pharmaceuticals (03933.HK) announced that on July 15, 2026, Federal Biotech has received US$13.5 million (after deducting Danish withholding tax) from Novo Nordisk for UBT251 injection global phase I clinical milestone payments for overweight or obesity indications.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.